The abuse of diuretics as performance‐enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis
- 18 August 2010
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 161 (1) , 1-16
Abstract
Diuretics are drugs that increase the rate of urine flow and sodium excretion to adjust the volume and composition of body fluids. There are several major categories of this drug class and the compounds vary greatly in structure, physicochemical properties, effects on urinary composition and renal haemodynamics, and site and mechanism of action. Diuretics are often abused by athletes to excrete water for rapid weight loss and to mask the presence of other banned substances. Because of their abuse by athletes, diuretics have been included on The World Anti‐Doping Agency's (WADA) list of prohibited substances; the use of diuretics is banned both in competition and out of competition and diuretics are routinely screened for by anti‐doping laboratories. This review provides an overview of the pharmacology and toxicology of diuretics and discusses their application in sports. The most common analytical strategies currently followed by the anti‐doping laboratories accredited by the WADA are discussed along with the challenges laboratories face for the analysis of this diverse class of drugs.Keywords
This publication has 67 references indexed in Scilit:
- Effects of acute exercise on insulin sensitivity, glucose effectiveness and disposition index in type 2 diabetic patientsDiabetes & Metabolism, 2008
- Drugs in SportBritish Journal of Pharmacology, 2008
- Hormone abuse in sports: the antidoping perspectiveAsian Journal of Andrology, 2008
- Rapid screening method for diuretics in doping control using automated solid phase extraction and liquid chromatography-electrospray tandem mass spectrometryAnalytica Chimica Acta, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- A Randomized, Placebo‐Controlled Study of Loop Diuretics in Patients with Essential Hypertension: The Bumetanide and Furosemide on Lipid Profile (BUFUL) Clinical Study ReportThe Journal of Clinical Pharmacology, 1998
- Drugs and SportSports Medicine, 1997
- Myocardial infarction, hyperkalaemia and ventricular tachycardia in a young male body-builderInternational Journal of Cardiology, 1994
- Influence of Antihypertensive Drugs on Exercise CapacityDrugs, 1993
- Diuretic Therapy and Exercise PerformanceSports Medicine, 1987